トリメチラミンN酸化物誘発性慢性腎臓損傷
1Department of Clinical Diagnostics, Hebei Medical University, Hebei, China. wuym@hebmu.edu.cn.
Physiological research
|August 31, 2025
まとめ
トリメチラミンN酸化物 (TMAO) は,ピロプトーシス,アポプトーシス,そしてネクロプトーシスを含む制御細胞死の一種であるパノプトーシスを誘発することで腎臓疾患に寄与し,腎臓線維症と機能障害を引き起こす.
科学分野:
- 生物化学
- 腎臓科
- 細胞生物学
背景:
- トリメチラミンN酸化物 (TMAO) は腎臓病の進行と関連しています.
- TMAOによる腎臓損傷の正確なメカニズムはほとんど不明です.
- 制御された細胞死経路は様々な臓器の損傷に関与している.
研究 の 目的:
- トリメチラミンN酸化物 (TMAO) 誘発の慢性腎損傷における細胞死亡の役割を調査する.
- TMAOによって腎臓で活性化される特定の細胞死経路を解明する.
主な方法:
- 慢性腎損傷のマウスモデルは,TMAOを3ヶ月間毎日の腹腔内注射によって確立された.
- 腎臓の機能は,血のクレアチニンと血中尿素の窒素濃度を測定することによって評価された.
- 腎臓の病理,線維症,アポプトーシス,ネクロプトーシス,ピロプトーシス,鉄代謝に関与する主要なタンパク質の発現は,マッソン染色とウエスタン・ブロッティングを用いて分析された.
主要な成果:
- TMAOの投与は,腎臓機能の障害を示唆する血クレアチニンと血中尿素の濃度を著しく上昇させた.
- ヒストロジカル分析では,TMAOを投与したグループで腎臓線維症が増加したことが明らかになった.
- ウェスタン・ブロット分析では,PANoptosis (カスパーゼ-8,NLRP3,IL- 1β,GSDMD,ZBP1,RIP3,MLKL) と鉄同位素 (TFR1,FTH,FPN,NRF2,GPX4) と関連したタンパク質の発現が著しく上昇し,鉄またはMDAのレベルは変化しなかった.
結論:
- ピロプトーシス,アポプトーシス,そしてネクロプトーシスを含むパノプトーシスは,TMAO誘発の慢性腎損傷に寄与する重要なメカニズムである.
- TMAOによる腎臓損傷は,複雑な細胞死経路と鉄代謝の調節因子の変化を含む.
- これらの発見は,TMAO関連の腎不全の病原性に関する新しい洞察を提供し,潜在的な治療目標を示唆しています.
さらに関連する動画
関連する概念動画
01:29Acute Kidney Injury II: Pathophysiology
72
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
72
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:10Nephrons
3.4K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.4K
01:28Chronic Kidney Disease III: Interprofessional Care
77
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
01:25Chronic Kidney Disease I: Introduction
65
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65